PLAY PODCASTS
An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer
Episode 52

An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer

Listen to Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.

Decera Clinical Education Infectious Disease Podcast · Linda-Gail Bekker MBChB DTM&H DCH FCP(SA) PhD, Maureen Luba

May 20, 202125m 23s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.

Presenters:

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  
Chief Operating Officer  
Desmond Tutu HIV Foundation  
Deputy Director
Desmond Tutu HIV Centre  
Past President
International AIDS Society  
Faculty of Health Sciences  
University of Cape Town  
Cape Town, South Africa

Maureen Luba
Africa Region Advocacy Advisor
Global Advocacy for HIV Prevention
AIDS Vaccine Advocacy Coalition

Link to full series:
https://bit.ly/3ytytMY

Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d

Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

treatment as preventionhiv advocacyhiv epidemichiv mrna vaccineshiv vaccinemosaicohiv community advocacyinternational aids societyantiretroviral therapyhiv preventionhiv prephiv politicshiv pre-exposure prophylaxishiv long-acting antiretroviral therapyrv144arthiv